Platelet-rich plasma (PRP) has been increasingly used in sports medicine owing to its various advantages. The purpose of our project was to standardize the parameters before performing large-scale clinical trials in the near future to precisely evaluate individual PRP quality. To examine the effects of regular exercise on PRP quality, this study focused on young female athletes, who have been relatively less studied. Blood samples were obtained from female college athletes (n = 35) and ordinary healthy adults (n = 30), which were considered as controls, and leukocyte-rich PRP (L-PRP) was prepared manually. Body composition indices were determined using a bathroom weight scale equipped with an impedance meter. Growth factors and cytokines were quantified using ELISA kits. Platelet-derived growth factor-BB (PDGF-BB) and Transforming-growth factors β1 (TGFβ1) levels (per platelet) in L-PRP were significantly lower in female athletes than in controls. In contrast, Interleukin-1β and Interleukin 1 receptor antagonist (IL-1RA) levels (per platelet and L-PRP) in L-PRP were significantly higher in athletes, and this difference was more prominent in IL-1RA. These findings suggest that L-PRP from athletes may facilitate the inflammatory phase of the healing process by regulating the pro-inflammatory and anti-inflammatory balance. These chemical compositions can be adopted as “must-check” parameters to characterize individual PRP preparations prior to clinical trials.
Autologous platelet-rich plasma (PRP) therapy has been becoming popular for the treatment of musculotendinous injuries among athletes. However, for individual and practical variations, clinical success is hardly predictable. To overcome this difficulty, we have been exploring possible criterion candidates for monitoring its clinical effectiveness. In this study, we focused on sex-based differences in young elite athletes and compared the biochemical compositions of their PRP. Leukocyte-rich PRP (L-PRP) was manually prepared from blood samples collected from male professional soccer players (mPSPs) (n = 25) and female college athletes (fCAs) (n = 36). Platelet-derived growth factor-BB (PDGF-BB), transforming-growth factor-β1 (TGFβ1), platelet factor-4 (PF4), interleukin-1β (IL-1β), and IL-1 receptor antagonist (IL-1RA) were quantified using an enzyme-linked immunosorbent assay. The levels of PDGF-BB, TGFβ1, and PF4 in L-PRP were significantly higher in mPSPs than in fCAs. Conversely, IL-1β and IL-1RA were detected at significantly and slightly higher levels, respectively, in fCAs than in mPSPs. Our findings suggest that, even though L-PRP from fCAs may have lower potential to induce cell growth and differentiation than that of mPSPs, due to the latter’s higher capacity to control inflammation, it does not necessarily imply that PRP treatment in fCAs is less effective. Thus, these cytokine levels should be checked before PRP therapy.
Background and Aims: Recently, an increasing number of athletes (from recreational to professional) have chosen autologous platelet‐rich plasma (PRP) therapy to treat their sports‐related injuries. However, its clinical outcomes vary among individuals and are thought to be influenced mainly by the athletes' PRP quality and physical condition. Thus, for successful PRP therapy, it is crucial to evaluate platelet activities in addition to soluble bioactive factors. In previous studies, we examined male professional athletes and female elite student‐athletes. To expand the findings, in this study, we focused on male recreational student‐athletes and characterized their platelet energetics. Methods: PRP was prepared from healthy male soccer club members (college student‐athletes, CA) and sedentary adults of similar ages (non‐athletes, NA) at rest. Plasma lactate, platelet adenosine triphosphate (ATP), and oxygen (O 2 ) consumption levels were quantified using biochemical and bioelectrical methods. Results: The body composition indices of the CA generally showed characteristics that fell between those of professional athletes and the NA. Changes in platelet lactate, ATP, or O 2 consumption levels, during the 24 h incubation period did not differ significantly between the two groups. Nevertheless, the changes in ATP levels were strongly and positively correlated with those in O 2 consumption only in the CA group. Conclusions: Energy generation in CAs' platelets is suggested to be more closely related to O 2 consumption than that of the NA. Habitual exercise may impact platelet energetics as well as muscle cell energetics; however, further validation should be conducted with large samples to provide more insights into this hypothesis.
Owing to its ability to promote early recovery, platelet-rich plasma (PRP) is a popular regenerative therapy for treating sports injuries. However, its scientific basis has not yet been fully established. To bridge this gap, we focused on systemic antioxidant capacity, which suppresses exacerbated inflammation. Plasma total antioxidant capacity (TAC) in male professional soccer athletes (n = 30) was assessed alongside body composition measurements and compared with that of non-athletes (n = 31). Metabolic and inflammatory conditions were examined using erythrocyte sedimentation rate and plasma lactate, glucose, and protein levels. TAC levels were similar in both groups. Moderate correlations were observed between TAC and body fat percentage, skeletal muscle percentage, and basal metabolic rate in the control group, but not in the pro-athlete group, which exhibited superior body composition indices. These findings suggest that TAC levels may not directly influence PRP therapy in athletes. However, when compared with TAC levels calculated using correlations obtained in controls, the measured TAC levels (329.3 mM) were substantially higher than the compensated levels (62.5 mM for basal metabolic rate) in pro-athletes. This analytical approach indicates that TAC may theoretically be elevated to higher levels in pro-athletes when evaluated using non-athlete-based scales.